| ||||||||
|
||||||||
|
||||||||
|
||||||||
| Or | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "S"
Results 271 - 280 of 2724 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| Garofalo, S R Bianco, S Garofalo, R Rosa, V Damiano, T Gelardi, G Daniele, R Marciano, F Ciardiello and G Tortora Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs advance online publication, 2008-03-04 00:00:00.000; doi:10.1038/sj.bjc.6604269 Abstract | Full article | PDF |
||||||||
| Garte, S V Paracchini, A Nanni Costa, S Garte and E Taioli Role of simian virus 40 in cancer incidence in solid organ transplant patients advance online publication, 2006-04-18 00:00:00.000; doi:10.1038/sj.bjc.6603107 Abstract | Full article | PDF |
||||||||
| Garvin, S S Garvin, U W Nilsson and C Dabrosin Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells advance online publication, 2005-10-18 00:00:00.000; doi:10.1038/sj.bjc.6602824 Abstract | Full article | PDF |
||||||||
| Gasperoni, S F Di Costanzo, P Carlini, L Doni, B Massidda, R Mattioli, A Iop, E Barletta, L Moscetti, F Recchia, P Tralongo and S Gasperoni Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) advance online publication, 2005-06-28 00:00:00.000; doi:10.1038/sj.bjc.6602640 Abstract | Full article | PDF |
||||||||
| Gayther, S A T Hagemann, T Bozanovic, S Hooper, A Ljubic, V I F Slettenaar, J L Wilson, N Singh, S A Gayther, J H Shepherd and P O A Van Trappen Molecular profiling of cervical cancer progression doi:10.1038/sj.bjc.6603543 Abstract | Full article | PDF C L Pearce, A H Wu, S A Gayther, A E Bale, P A Beck, J Beesley, S Chanock, D W Cramer, R DiCioccio, R Edwards, Z S Fredericksen, M García-Closas, E L Goode, A C Green, L C Hartmann, E Hogdall, S K Kjær, J Lissowska, V McGuire, F Modugno, K Moysich, R B Ness, S J Ramus, H A Risch, T A Sellers, H Song, D O Stram, K L Terry, P M Webb, D C Whiteman, A S Whittemore, W Zheng, P D P Pharoah, G Chenevix-Trench, M C Pike, J Schildkraut and A Berchuck Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis advance online publication, 2008-01-22 00:00:00.000; doi:10.1038/sj.bjc.6604170 Abstract | Full article | PDF |
||||||||
| Gebhard, S M Hermes, W Schormann, M Brulport, K Uhlemann, F Lupatsch, L C Horn, A Schumann, C Allgaier, M Weishaupt, K Engeland, G A Müller, J Mössner, A Bauer, I B Schiffer, S Gebhard, M Schmidt, E Lausch, D Prawitt, C Wilhelm and J G Hengstler Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model advance online publication, 2008-04-29 00:00:00.000; doi:10.1038/sj.bjc.6604318 Abstract | Full article | PDF |
||||||||
| Gebhardt, S M Schmidt, E Bremer, D Hasenclever, A Victor, M Gehrmann, E Steiner, I B Schiffer, S Gebhardt, H-A Lehr, M Mahlke, M Hermes, A Mustea, B Tanner, H Koelbl, H Pilch and J G Hengstler Role of the progesterone receptor for paclitaxel resistance in primary breast cancer advance online publication, 2007-01-09 00:00:00.000; doi:10.1038/sj.bjc.6603538 Abstract | Full article | PDF |
||||||||
| George, S S George, J Primrose, R Talbot, J Smith, M Mullee, D Bailey, C du Boulay and H Jordan Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists advance online publication, 2006-09-12 00:00:00.000; doi:10.1038/sj.bjc.6603352 Abstract | Full article | PDF |
||||||||
| Gerson, S Z Tang, R Du, S Jiang, C Wu, D S Barkauskas, J Richey, J Molter, M Lam, C Flask, S Gerson, A Dowlati, L Liu, Z Lee, B Halmos, Y Wang, J A Kern and P C Ma Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer advance online publication, 2008-08-26 00:00:00.000; doi:10.1038/sj.bjc.6604559 Abstract | Full article | PDF |
||||||||
| Ghosh, S C Feder-Mengus, S Ghosh, W P Weber, S Wyler, P Zajac, L Terracciano, D Oertli, M Heberer, I Martin, G C Spagnoli and A Reschner Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes advance online publication, 2007-03-06 00:00:00.000; doi:10.1038/sj.bjc.6603664 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||